Schreiber, R., Lewis, C. and Crane, K. (2018) “Patient Assessment of Foam Attributes from the Tazarotene Foam, 0.1%, Phase III Trials and Potential Impact on Patient Compliance”, SKIN The Journal of Cutaneous Medicine, 2, p. S57. doi: 10.25251/skin.2.supp.57.